nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCC1—Vandetanib—thyroid cancer	0.114	0.154	CbGbCtD
Glyburide—ABCC1—Epirubicin—thyroid cancer	0.0787	0.106	CbGbCtD
Glyburide—ABCG2—Vandetanib—thyroid cancer	0.0765	0.103	CbGbCtD
Glyburide—ABCC3—Doxorubicin—thyroid cancer	0.0681	0.0915	CbGbCtD
Glyburide—ABCB11—Doxorubicin—thyroid cancer	0.0589	0.0791	CbGbCtD
Glyburide—ALB—Vandetanib—thyroid cancer	0.0528	0.0709	CbGbCtD
Glyburide—ABCC2—Sorafenib—thyroid cancer	0.051	0.0685	CbGbCtD
Glyburide—ABCG2—Sorafenib—thyroid cancer	0.0461	0.062	CbGbCtD
Glyburide—ABCC1—Doxorubicin—thyroid cancer	0.0418	0.0562	CbGbCtD
Glyburide—ABCC2—Doxorubicin—thyroid cancer	0.031	0.0416	CbGbCtD
Glyburide—ABCG2—Doxorubicin—thyroid cancer	0.028	0.0376	CbGbCtD
Glyburide—CYP2C19—Sorafenib—thyroid cancer	0.0206	0.0277	CbGbCtD
Glyburide—CYP2C9—Sorafenib—thyroid cancer	0.0171	0.023	CbGbCtD
Glyburide—ABCB1—Sorafenib—thyroid cancer	0.0166	0.0223	CbGbCtD
Glyburide—CYP3A4—Vandetanib—thyroid cancer	0.0165	0.0222	CbGbCtD
Glyburide—ABCB1—Doxorubicin—thyroid cancer	0.0101	0.0136	CbGbCtD
Glyburide—CYP3A4—Sorafenib—thyroid cancer	0.00997	0.0134	CbGbCtD
Glyburide—CYP3A4—Doxorubicin—thyroid cancer	0.00605	0.00812	CbGbCtD
Glyburide—Allergic cutaneous angiitis—Sorafenib—thyroid cancer	0.00497	0.0461	CcSEcCtD
Glyburide—Nephropathy—Vandetanib—thyroid cancer	0.00493	0.0456	CcSEcCtD
Glyburide—KCNJ5—head—thyroid cancer	0.0033	0.0714	CbGeAlD
Glyburide—Leukocytoclastic vasculitis—Sorafenib—thyroid cancer	0.00323	0.0299	CcSEcCtD
Glyburide—CFTR—saliva-secreting gland—thyroid cancer	0.00296	0.064	CbGeAlD
Glyburide—ABCC9—thyroid gland—thyroid cancer	0.00282	0.061	CbGeAlD
Glyburide—Lactic acidosis—Epirubicin—thyroid cancer	0.00239	0.0222	CcSEcCtD
Glyburide—CFTR—trachea—thyroid cancer	0.00228	0.0494	CbGeAlD
Glyburide—Lactic acidosis—Doxorubicin—thyroid cancer	0.00222	0.0205	CcSEcCtD
Glyburide—CPT1A—thyroid gland—thyroid cancer	0.00205	0.0444	CbGeAlD
Glyburide—Glipizide—PPARG—thyroid cancer	0.00205	0.578	CrCbGaD
Glyburide—ABCA1—thyroid gland—thyroid cancer	0.00191	0.0414	CbGeAlD
Glyburide—CPT1A—head—thyroid cancer	0.00182	0.0394	CbGeAlD
Glyburide—KCNJ1—head—thyroid cancer	0.00178	0.0386	CbGeAlD
Glyburide—Dermatitis bullous—Vandetanib—thyroid cancer	0.00178	0.0165	CcSEcCtD
Glyburide—ABCC9—lymph node—thyroid cancer	0.00175	0.0379	CbGeAlD
Glyburide—Hypoglycaemia—Vandetanib—thyroid cancer	0.00174	0.0162	CcSEcCtD
Glyburide—Hyponatraemia—Vandetanib—thyroid cancer	0.00171	0.0158	CcSEcCtD
Glyburide—ABCA1—head—thyroid cancer	0.0017	0.0367	CbGeAlD
Glyburide—CFTR—head—thyroid cancer	0.0016	0.0347	CbGeAlD
Glyburide—Bezafibrate—PPARG—thyroid cancer	0.00149	0.422	CrCbGaD
Glyburide—Pancreatitis—Vandetanib—thyroid cancer	0.00144	0.0134	CcSEcCtD
Glyburide—Photosensitivity reaction—Vandetanib—thyroid cancer	0.00134	0.0124	CcSEcCtD
Glyburide—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00131	0.0122	CcSEcCtD
Glyburide—Hepatic failure—Sorafenib—thyroid cancer	0.00128	0.0118	CcSEcCtD
Glyburide—CPT1A—lymph node—thyroid cancer	0.00127	0.0276	CbGeAlD
Glyburide—Myelosuppression—Epirubicin—thyroid cancer	0.00125	0.0115	CcSEcCtD
Glyburide—Renal failure acute—Sorafenib—thyroid cancer	0.00124	0.0115	CcSEcCtD
Glyburide—KCNJ11—thyroid gland—thyroid cancer	0.00122	0.0264	CbGeAlD
Glyburide—Kidney function abnormal—Epirubicin—thyroid cancer	0.00121	0.0112	CcSEcCtD
Glyburide—ABCA1—lymph node—thyroid cancer	0.00119	0.0257	CbGeAlD
Glyburide—Myelosuppression—Doxorubicin—thyroid cancer	0.00115	0.0107	CcSEcCtD
Glyburide—Hyponatraemia—Sorafenib—thyroid cancer	0.00115	0.0107	CcSEcCtD
Glyburide—Visual impairment—Vandetanib—thyroid cancer	0.00113	0.0105	CcSEcCtD
Glyburide—ABCC8—thyroid gland—thyroid cancer	0.00112	0.0243	CbGeAlD
Glyburide—Kidney function abnormal—Doxorubicin—thyroid cancer	0.00112	0.0104	CcSEcCtD
Glyburide—Eye disorder—Vandetanib—thyroid cancer	0.0011	0.0102	CcSEcCtD
Glyburide—SLC15A2—saliva-secreting gland—thyroid cancer	0.0011	0.0238	CbGeAlD
Glyburide—KCNJ11—head—thyroid cancer	0.00108	0.0234	CbGeAlD
Glyburide—Blindness—Epirubicin—thyroid cancer	0.00106	0.00978	CcSEcCtD
Glyburide—Alopecia—Vandetanib—thyroid cancer	0.00104	0.00964	CcSEcCtD
Glyburide—Malnutrition—Vandetanib—thyroid cancer	0.00103	0.0095	CcSEcCtD
Glyburide—ABCC8—head—thyroid cancer	0.000996	0.0215	CbGeAlD
Glyburide—Blindness—Doxorubicin—thyroid cancer	0.000977	0.00905	CcSEcCtD
Glyburide—Pancreatitis—Sorafenib—thyroid cancer	0.000973	0.00901	CcSEcCtD
Glyburide—Vision blurred—Vandetanib—thyroid cancer	0.000966	0.00895	CcSEcCtD
Glyburide—Tremor—Vandetanib—thyroid cancer	0.00096	0.0089	CcSEcCtD
Glyburide—Eruption—Epirubicin—thyroid cancer	0.00095	0.0088	CcSEcCtD
Glyburide—ABCC3—thyroid gland—thyroid cancer	0.000943	0.0204	CbGeAlD
Glyburide—ABCG2—saliva-secreting gland—thyroid cancer	0.0009	0.0195	CbGeAlD
Glyburide—Convulsion—Vandetanib—thyroid cancer	0.000888	0.00823	CcSEcCtD
Glyburide—Eruption—Doxorubicin—thyroid cancer	0.000879	0.00815	CcSEcCtD
Glyburide—SLCO2B1—thyroid gland—thyroid cancer	0.000879	0.019	CbGeAlD
Glyburide—Arthralgia—Vandetanib—thyroid cancer	0.000873	0.00809	CcSEcCtD
Glyburide—Jaundice—Sorafenib—thyroid cancer	0.000863	0.00799	CcSEcCtD
Glyburide—SLC15A2—trachea—thyroid cancer	0.000848	0.0183	CbGeAlD
Glyburide—ABCC1—trachea—thyroid cancer	0.000839	0.0181	CbGeAlD
Glyburide—Oedema—Vandetanib—thyroid cancer	0.000837	0.00775	CcSEcCtD
Glyburide—ABCC3—head—thyroid cancer	0.000836	0.0181	CbGeAlD
Glyburide—Nervous system disorder—Vandetanib—thyroid cancer	0.000821	0.0076	CcSEcCtD
Glyburide—Thrombocytopenia—Vandetanib—thyroid cancer	0.000819	0.00759	CcSEcCtD
Glyburide—SLCO2B1—head—thyroid cancer	0.000779	0.0169	CbGeAlD
Glyburide—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000762	0.00706	CcSEcCtD
Glyburide—KCNJ11—lymph node—thyroid cancer	0.000757	0.0164	CbGeAlD
Glyburide—Paraesthesia—Vandetanib—thyroid cancer	0.000751	0.00696	CcSEcCtD
Glyburide—Dyspnoea—Vandetanib—thyroid cancer	0.000746	0.00691	CcSEcCtD
Glyburide—Dyspepsia—Vandetanib—thyroid cancer	0.000736	0.00682	CcSEcCtD
Glyburide—Decreased appetite—Vandetanib—thyroid cancer	0.000727	0.00674	CcSEcCtD
Glyburide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000722	0.00669	CcSEcCtD
Glyburide—SLCO1A2—head—thyroid cancer	0.000717	0.0155	CbGeAlD
Glyburide—Alopecia—Sorafenib—thyroid cancer	0.000702	0.0065	CcSEcCtD
Glyburide—Erythema—Sorafenib—thyroid cancer	0.000692	0.00641	CcSEcCtD
Glyburide—Malnutrition—Sorafenib—thyroid cancer	0.000692	0.00641	CcSEcCtD
Glyburide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000684	0.00634	CcSEcCtD
Glyburide—SLC15A2—thyroid gland—thyroid cancer	0.000671	0.0145	CbGeAlD
Glyburide—Jaundice cholestatic—Epirubicin—thyroid cancer	0.000665	0.00616	CcSEcCtD
Glyburide—ABCC1—thyroid gland—thyroid cancer	0.000663	0.0144	CbGeAlD
Glyburide—Abdominal pain—Vandetanib—thyroid cancer	0.000661	0.00613	CcSEcCtD
Glyburide—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.000643	0.00596	CcSEcCtD
Glyburide—Anaemia—Sorafenib—thyroid cancer	0.000639	0.00592	CcSEcCtD
Glyburide—Angioedema—Sorafenib—thyroid cancer	0.000632	0.00585	CcSEcCtD
Glyburide—Leukopenia—Sorafenib—thyroid cancer	0.000619	0.00573	CcSEcCtD
Glyburide—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.000616	0.0057	CcSEcCtD
Glyburide—Asthenia—Vandetanib—thyroid cancer	0.0006	0.00556	CcSEcCtD
Glyburide—SLC15A2—head—thyroid cancer	0.000595	0.0129	CbGeAlD
Glyburide—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.000595	0.00551	CcSEcCtD
Glyburide—Pruritus—Vandetanib—thyroid cancer	0.000592	0.00548	CcSEcCtD
Glyburide—Arthralgia—Sorafenib—thyroid cancer	0.000589	0.00545	CcSEcCtD
Glyburide—Myalgia—Sorafenib—thyroid cancer	0.000589	0.00545	CcSEcCtD
Glyburide—ABCC3—lymph node—thyroid cancer	0.000586	0.0127	CbGeAlD
Glyburide—Diarrhoea—Vandetanib—thyroid cancer	0.000572	0.0053	CcSEcCtD
Glyburide—Shock—Sorafenib—thyroid cancer	0.000555	0.00514	CcSEcCtD
Glyburide—Nervous system disorder—Sorafenib—thyroid cancer	0.000553	0.00513	CcSEcCtD
Glyburide—Thrombocytopenia—Sorafenib—thyroid cancer	0.000553	0.00512	CcSEcCtD
Glyburide—ABCG2—thyroid gland—thyroid cancer	0.000549	0.0119	CbGeAlD
Glyburide—Aplastic anaemia—Epirubicin—thyroid cancer	0.000549	0.00508	CcSEcCtD
Glyburide—SLCO2B1—lymph node—thyroid cancer	0.000546	0.0118	CbGeAlD
Glyburide—Anorexia—Sorafenib—thyroid cancer	0.000538	0.00498	CcSEcCtD
Glyburide—Vomiting—Vandetanib—thyroid cancer	0.000532	0.00493	CcSEcCtD
Glyburide—Rash—Vandetanib—thyroid cancer	0.000528	0.00489	CcSEcCtD
Glyburide—Dermatitis—Vandetanib—thyroid cancer	0.000527	0.00488	CcSEcCtD
Glyburide—Headache—Vandetanib—thyroid cancer	0.000524	0.00486	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000514	0.00476	CcSEcCtD
Glyburide—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000508	0.0047	CcSEcCtD
Glyburide—Dyspnoea—Sorafenib—thyroid cancer	0.000503	0.00466	CcSEcCtD
Glyburide—ALB—lymph node—thyroid cancer	0.000499	0.0108	CbGeAlD
Glyburide—Nausea—Vandetanib—thyroid cancer	0.000497	0.0046	CcSEcCtD
Glyburide—Dyspepsia—Sorafenib—thyroid cancer	0.000497	0.0046	CcSEcCtD
Glyburide—Decreased appetite—Sorafenib—thyroid cancer	0.000491	0.00454	CcSEcCtD
Glyburide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000487	0.00451	CcSEcCtD
Glyburide—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000486	0.0045	CcSEcCtD
Glyburide—Vascular purpura—Epirubicin—thyroid cancer	0.000474	0.00439	CcSEcCtD
Glyburide—Hepatic failure—Epirubicin—thyroid cancer	0.000472	0.00437	CcSEcCtD
Glyburide—ABCC2—lymph node—thyroid cancer	0.000468	0.0101	CbGeAlD
Glyburide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000462	0.00428	CcSEcCtD
Glyburide—Renal failure acute—Epirubicin—thyroid cancer	0.00046	0.00426	CcSEcCtD
Glyburide—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000449	0.00416	CcSEcCtD
Glyburide—Urticaria—Sorafenib—thyroid cancer	0.000448	0.00415	CcSEcCtD
Glyburide—Abdominal pain—Sorafenib—thyroid cancer	0.000446	0.00413	CcSEcCtD
Glyburide—Renal impairment—Epirubicin—thyroid cancer	0.000446	0.00413	CcSEcCtD
Glyburide—Dermatitis bullous—Epirubicin—thyroid cancer	0.000444	0.00411	CcSEcCtD
Glyburide—Purpura—Epirubicin—thyroid cancer	0.00044	0.00408	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—thyroid cancer	0.000439	0.00407	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—thyroid cancer	0.000437	0.00405	CcSEcCtD
Glyburide—Hypoglycaemia—Epirubicin—thyroid cancer	0.000435	0.00403	CcSEcCtD
Glyburide—Hyponatraemia—Epirubicin—thyroid cancer	0.000426	0.00395	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—thyroid cancer	0.000425	0.00394	CcSEcCtD
Glyburide—Diplopia—Epirubicin—thyroid cancer	0.000424	0.00393	CcSEcCtD
Glyburide—SLC15A2—lymph node—thyroid cancer	0.000417	0.00902	CbGeAlD
Glyburide—Hypersensitivity—Sorafenib—thyroid cancer	0.000416	0.00385	CcSEcCtD
Glyburide—Renal impairment—Doxorubicin—thyroid cancer	0.000413	0.00382	CcSEcCtD
Glyburide—ABCC1—lymph node—thyroid cancer	0.000412	0.00892	CbGeAlD
Glyburide—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000411	0.00381	CcSEcCtD
Glyburide—Purpura—Doxorubicin—thyroid cancer	0.000407	0.00377	CcSEcCtD
Glyburide—Asthenia—Sorafenib—thyroid cancer	0.000405	0.00375	CcSEcCtD
Glyburide—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000402	0.00373	CcSEcCtD
Glyburide—Pruritus—Sorafenib—thyroid cancer	0.000399	0.0037	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—thyroid cancer	0.000394	0.00365	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—thyroid cancer	0.000393	0.00364	CcSEcCtD
Glyburide—Diarrhoea—Sorafenib—thyroid cancer	0.000386	0.00358	CcSEcCtD
Glyburide—Abdominal distension—Epirubicin—thyroid cancer	0.000369	0.00342	CcSEcCtD
Glyburide—Eosinophilia—Epirubicin—thyroid cancer	0.000363	0.00336	CcSEcCtD
Glyburide—Pancreatitis—Epirubicin—thyroid cancer	0.00036	0.00333	CcSEcCtD
Glyburide—Vomiting—Sorafenib—thyroid cancer	0.000359	0.00332	CcSEcCtD
Glyburide—Rash—Sorafenib—thyroid cancer	0.000356	0.0033	CcSEcCtD
Glyburide—Dermatitis—Sorafenib—thyroid cancer	0.000356	0.00329	CcSEcCtD
Glyburide—Headache—Sorafenib—thyroid cancer	0.000354	0.00328	CcSEcCtD
Glyburide—Pancytopenia—Epirubicin—thyroid cancer	0.000348	0.00323	CcSEcCtD
Glyburide—ABCB1—trachea—thyroid cancer	0.000342	0.00741	CbGeAlD
Glyburide—Abdominal distension—Doxorubicin—thyroid cancer	0.000342	0.00317	CcSEcCtD
Glyburide—ABCG2—lymph node—thyroid cancer	0.000341	0.00738	CbGeAlD
Glyburide—Eosinophilia—Doxorubicin—thyroid cancer	0.000336	0.00311	CcSEcCtD
Glyburide—Nausea—Sorafenib—thyroid cancer	0.000335	0.00311	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000335	0.0031	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—thyroid cancer	0.000333	0.00308	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—thyroid cancer	0.000322	0.00299	CcSEcCtD
Glyburide—Jaundice—Epirubicin—thyroid cancer	0.000319	0.00295	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00031	0.00287	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—thyroid cancer	0.000305	0.00283	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—thyroid cancer	0.000295	0.00273	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—thyroid cancer	0.000294	0.00272	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—thyroid cancer	0.000283	0.00262	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—thyroid cancer	0.000282	0.00262	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—thyroid cancer	0.000274	0.00254	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—thyroid cancer	0.000272	0.00252	CcSEcCtD
Glyburide—ABCB1—thyroid gland—thyroid cancer	0.000271	0.00586	CbGeAlD
Glyburide—Visual impairment—Doxorubicin—thyroid cancer	0.000262	0.00243	CcSEcCtD
Glyburide—Alopecia—Epirubicin—thyroid cancer	0.000259	0.0024	CcSEcCtD
Glyburide—Erythema—Epirubicin—thyroid cancer	0.000256	0.00237	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—thyroid cancer	0.000256	0.00237	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—thyroid cancer	0.000254	0.00235	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—thyroid cancer	0.000241	0.00223	CcSEcCtD
Glyburide—ABCB1—head—thyroid cancer	0.00024	0.0052	CbGeAlD
Glyburide—Alopecia—Doxorubicin—thyroid cancer	0.00024	0.00222	CcSEcCtD
Glyburide—Erythema—Doxorubicin—thyroid cancer	0.000236	0.00219	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—thyroid cancer	0.000236	0.00219	CcSEcCtD
Glyburide—Anaemia—Epirubicin—thyroid cancer	0.000236	0.00219	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—thyroid cancer	0.000229	0.00212	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—thyroid cancer	0.000223	0.00206	CcSEcCtD
Glyburide—Convulsion—Epirubicin—thyroid cancer	0.000221	0.00205	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—thyroid cancer	0.000219	0.00202	CcSEcCtD
Glyburide—Myalgia—Epirubicin—thyroid cancer	0.000218	0.00202	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—thyroid cancer	0.000218	0.00202	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—thyroid cancer	0.000212	0.00196	CcSEcCtD
Glyburide—Confusional state—Epirubicin—thyroid cancer	0.00021	0.00195	CcSEcCtD
Glyburide—Oedema—Epirubicin—thyroid cancer	0.000209	0.00193	CcSEcCtD
Glyburide—Shock—Epirubicin—thyroid cancer	0.000205	0.0019	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—thyroid cancer	0.000205	0.0019	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—thyroid cancer	0.000205	0.00189	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—thyroid cancer	0.000204	0.00189	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—thyroid cancer	0.000202	0.00187	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—thyroid cancer	0.000201	0.00187	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—thyroid cancer	0.000201	0.00187	CcSEcCtD
Glyburide—Anorexia—Epirubicin—thyroid cancer	0.000199	0.00184	CcSEcCtD
Glyburide—Hypotension—Epirubicin—thyroid cancer	0.000195	0.00181	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—thyroid cancer	0.000195	0.0018	CcSEcCtD
Glyburide—Oedema—Doxorubicin—thyroid cancer	0.000193	0.00179	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00019	0.00176	CcSEcCtD
Glyburide—Shock—Doxorubicin—thyroid cancer	0.00019	0.00176	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—thyroid cancer	0.000189	0.00175	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000189	0.00175	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—thyroid cancer	0.000187	0.00174	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000187	0.00173	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—thyroid cancer	0.000186	0.00172	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—thyroid cancer	0.000184	0.0017	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—thyroid cancer	0.000184	0.0017	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—thyroid cancer	0.000181	0.00168	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—thyroid cancer	0.00018	0.00167	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00018	0.00167	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000176	0.00163	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—thyroid cancer	0.000173	0.00161	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—thyroid cancer	0.000172	0.00159	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—thyroid cancer	0.000172	0.00159	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000171	0.00158	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—thyroid cancer	0.00017	0.00157	CcSEcCtD
Glyburide—ABCB1—lymph node—thyroid cancer	0.000168	0.00364	CbGeAlD
Glyburide—Decreased appetite—Doxorubicin—thyroid cancer	0.000168	0.00155	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000167	0.00154	CcSEcCtD
Glyburide—Urticaria—Epirubicin—thyroid cancer	0.000166	0.00154	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—thyroid cancer	0.000165	0.00153	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—thyroid cancer	0.000159	0.00147	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000158	0.00146	CcSEcCtD
Glyburide—Hypersensitivity—Epirubicin—thyroid cancer	0.000154	0.00142	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—thyroid cancer	0.000153	0.00142	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—thyroid cancer	0.000153	0.00141	CcSEcCtD
Glyburide—Asthenia—Epirubicin—thyroid cancer	0.00015	0.00139	CcSEcCtD
Glyburide—Pruritus—Epirubicin—thyroid cancer	0.000148	0.00137	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—thyroid cancer	0.000143	0.00132	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—thyroid cancer	0.000142	0.00132	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—thyroid cancer	0.000138	0.00128	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—thyroid cancer	0.000137	0.00126	CcSEcCtD
Glyburide—Vomiting—Epirubicin—thyroid cancer	0.000133	0.00123	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—thyroid cancer	0.000132	0.00122	CcSEcCtD
Glyburide—Rash—Epirubicin—thyroid cancer	0.000132	0.00122	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—thyroid cancer	0.000131	0.00122	CcSEcCtD
Glyburide—Headache—Epirubicin—thyroid cancer	0.000131	0.00121	CcSEcCtD
Glyburide—Nausea—Epirubicin—thyroid cancer	0.000124	0.00115	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—thyroid cancer	0.000123	0.00114	CcSEcCtD
Glyburide—Rash—Doxorubicin—thyroid cancer	0.000122	0.00113	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—thyroid cancer	0.000122	0.00113	CcSEcCtD
Glyburide—Headache—Doxorubicin—thyroid cancer	0.000121	0.00112	CcSEcCtD
Glyburide—Nausea—Doxorubicin—thyroid cancer	0.000115	0.00106	CcSEcCtD
Glyburide—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	8.48e-05	0.000866	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—HPGD—thyroid cancer	8.45e-05	0.000863	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.34e-05	0.000852	CbGpPWpGaD
Glyburide—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	8.29e-05	0.000847	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	8.21e-05	0.000839	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	8.21e-05	0.000839	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CHST14—thyroid cancer	8.21e-05	0.000839	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	8.12e-05	0.000829	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	8.12e-05	0.000829	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.08e-05	0.000825	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.07e-05	0.000824	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.99e-05	0.000815	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—SLC5A5—thyroid cancer	7.76e-05	0.000792	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—SLC5A5—thyroid cancer	7.76e-05	0.000792	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.75e-05	0.000792	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.74e-05	0.00079	CbGpPWpGaD
Glyburide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.72e-05	0.000788	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—NDUFA13—thyroid cancer	7.69e-05	0.000785	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.6e-05	0.000776	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—HPGD—thyroid cancer	7.36e-05	0.000751	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.27e-05	0.000742	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.27e-05	0.000742	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.24e-05	0.00074	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CHST14—thyroid cancer	7.23e-05	0.000738	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.18e-05	0.000734	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.15e-05	0.00073	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	7.14e-05	0.000729	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	7.14e-05	0.000729	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.03e-05	0.000718	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.85e-05	0.0007	CbGpPWpGaD
Glyburide—CYP2C19—Biological oxidations—RXRA—thyroid cancer	6.82e-05	0.000696	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.75e-05	0.00069	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—HPGD—thyroid cancer	6.62e-05	0.000676	CbGpPWpGaD
Glyburide—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	6.61e-05	0.000675	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.61e-05	0.000675	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—RXRA—thyroid cancer	6.52e-05	0.000666	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—RXRA—thyroid cancer	6.52e-05	0.000666	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.52e-05	0.000665	CbGpPWpGaD
Glyburide—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	6.49e-05	0.000663	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	6.45e-05	0.000658	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—TPR—thyroid cancer	6.4e-05	0.000654	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.35e-05	0.000648	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.34e-05	0.000647	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.34e-05	0.000647	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PRKAR1A—thyroid cancer	6.3e-05	0.000643	CbGpPWpGaD
Glyburide—CYP2C9—Biological oxidations—RXRA—thyroid cancer	6.21e-05	0.000635	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—TPR—thyroid cancer	6.21e-05	0.000634	CbGpPWpGaD
Glyburide—ABCC1—Disease—TCF7L1—thyroid cancer	6.2e-05	0.000633	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.15e-05	0.000628	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	6.12e-05	0.000625	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PRKAR1A—thyroid cancer	6.11e-05	0.000624	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.08e-05	0.000621	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.97e-05	0.000609	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—HPGD—thyroid cancer	5.82e-05	0.000595	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.67e-05	0.000579	CbGpPWpGaD
Glyburide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	5.64e-05	0.000576	CbGpPWpGaD
Glyburide—ALB—Metabolism—MINPP1—thyroid cancer	5.58e-05	0.00057	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.37e-05	0.000548	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.35e-05	0.000546	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.33e-05	0.000545	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.17e-05	0.000528	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.11e-05	0.000521	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—TPR—thyroid cancer	5.06e-05	0.000517	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PRKAR1A—thyroid cancer	5.01e-05	0.000511	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—MINPP1—thyroid cancer	5.01e-05	0.000511	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PRKAR1A—thyroid cancer	4.98e-05	0.000508	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MINPP1—thyroid cancer	4.89e-05	0.000499	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—TPR—thyroid cancer	4.85e-05	0.000495	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TP53—thyroid cancer	4.83e-05	0.000493	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—SLC5A5—thyroid cancer	4.79e-05	0.000489	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PRKAR1A—thyroid cancer	4.77e-05	0.000487	CbGpPWpGaD
Glyburide—ALB—Metabolism—NDUFA13—thyroid cancer	4.74e-05	0.000484	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—SLC5A5—thyroid cancer	4.65e-05	0.000475	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MINPP1—thyroid cancer	4.57e-05	0.000466	CbGpPWpGaD
Glyburide—ABCC1—Disease—TPR—thyroid cancer	4.54e-05	0.000464	CbGpPWpGaD
Glyburide—ABCC8—Neuronal System—HRAS—thyroid cancer	4.52e-05	0.000462	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.51e-05	0.000461	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.49e-05	0.000459	CbGpPWpGaD
Glyburide—ABCC1—Disease—PRKAR1A—thyroid cancer	4.47e-05	0.000456	CbGpPWpGaD
Glyburide—ALB—Metabolism—CHST14—thyroid cancer	4.46e-05	0.000455	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	4.41e-05	0.00045	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	4.41e-05	0.00045	CbGpPWpGaD
Glyburide—KCNJ11—Neuronal System—HRAS—thyroid cancer	4.38e-05	0.000448	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.34e-05	0.000443	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.33e-05	0.000442	CbGpPWpGaD
Glyburide—ABCC1—Disease—MEN1—thyroid cancer	4.27e-05	0.000436	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NDUFA13—thyroid cancer	4.26e-05	0.000435	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—TPR—thyroid cancer	4.22e-05	0.000431	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	4.16e-05	0.000424	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NDUFA13—thyroid cancer	4.16e-05	0.000424	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PPARG—thyroid cancer	4.12e-05	0.00042	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PPARG—thyroid cancer	4.12e-05	0.00042	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—RXRA—thyroid cancer	4.1e-05	0.000419	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—RXRA—thyroid cancer	4.03e-05	0.000411	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CHST14—thyroid cancer	4e-05	0.000409	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CHST14—thyroid cancer	3.91e-05	0.000399	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—RXRA—thyroid cancer	3.9e-05	0.000399	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.88e-05	0.000396	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.86e-05	0.000394	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.86e-05	0.000394	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—TPR—thyroid cancer	3.8e-05	0.000388	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.8e-05	0.000388	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—SLC5A5—thyroid cancer	3.79e-05	0.000387	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.77e-05	0.000385	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PRKAR1A—thyroid cancer	3.74e-05	0.000382	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CHST14—thyroid cancer	3.65e-05	0.000373	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—SLC5A5—thyroid cancer	3.63e-05	0.000371	CbGpPWpGaD
Glyburide—ALB—Metabolism—HPGD—thyroid cancer	3.59e-05	0.000367	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.57e-05	0.000365	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.55e-05	0.000363	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.4e-05	0.000348	CbGpPWpGaD
Glyburide—ABCC1—Disease—CALCA—thyroid cancer	3.4e-05	0.000347	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.39e-05	0.000346	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—TPR—thyroid cancer	3.35e-05	0.000342	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IFNA2—thyroid cancer	3.32e-05	0.000339	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.3e-05	0.000337	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PRKAR1A—thyroid cancer	3.29e-05	0.000336	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PTGS2—thyroid cancer	3.24e-05	0.000331	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PTGS2—thyroid cancer	3.24e-05	0.000331	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HPGD—thyroid cancer	3.23e-05	0.000329	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—RXRA—thyroid cancer	3.18e-05	0.000325	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	3.16e-05	0.000323	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HPGD—thyroid cancer	3.15e-05	0.000322	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.1e-05	0.000316	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDK1—thyroid cancer	3.08e-05	0.000314	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—RXRA—thyroid cancer	3.05e-05	0.000312	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.04e-05	0.00031	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.01e-05	0.000307	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.97e-05	0.000303	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.96e-05	0.000303	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HPGD—thyroid cancer	2.94e-05	0.0003	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.92e-05	0.000298	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.89e-05	0.000295	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—SLC5A5—thyroid cancer	2.85e-05	0.000291	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PTEN—thyroid cancer	2.82e-05	0.000288	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PTEN—thyroid cancer	2.82e-05	0.000288	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.77e-05	0.000283	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.75e-05	0.00028	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.67e-05	0.000272	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—RXRA—thyroid cancer	2.66e-05	0.000271	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.65e-05	0.000271	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.62e-05	0.000267	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.58e-05	0.000264	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.56e-05	0.000261	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PPARG—thyroid cancer	2.54e-05	0.00026	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.5e-05	0.000256	CbGpPWpGaD
Glyburide—ABCC1—Disease—NRG1—thyroid cancer	2.47e-05	0.000252	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PPARG—thyroid cancer	2.47e-05	0.000252	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.43e-05	0.000248	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CHST14—thyroid cancer	2.41e-05	0.000246	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—RXRA—thyroid cancer	2.39e-05	0.000244	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.39e-05	0.000244	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.33e-05	0.000237	CbGpPWpGaD
Glyburide—ABCC1—Disease—TERT—thyroid cancer	2.22e-05	0.000226	CbGpPWpGaD
Glyburide—ABCC1—Disease—HIF1A—thyroid cancer	2.12e-05	0.000217	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—RXRA—thyroid cancer	2.1e-05	0.000215	CbGpPWpGaD
Glyburide—ALB—Metabolism—TPR—thyroid cancer	2.06e-05	0.000211	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.03e-05	0.000208	CbGpPWpGaD
Glyburide—ALB—Metabolism—PRKAR1A—thyroid cancer	2.03e-05	0.000207	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PPARG—thyroid cancer	2.01e-05	0.000205	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTGS2—thyroid cancer	2e-05	0.000204	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HPGD—thyroid cancer	1.94e-05	0.000198	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTGS2—thyroid cancer	1.94e-05	0.000198	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PPARG—thyroid cancer	1.93e-05	0.000197	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TPR—thyroid cancer	1.85e-05	0.000189	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.84e-05	0.000188	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.82e-05	0.000186	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TPR—thyroid cancer	1.81e-05	0.000185	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.81e-05	0.000185	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.78e-05	0.000182	CbGpPWpGaD
Glyburide—ABCC1—Disease—BRAF—thyroid cancer	1.76e-05	0.000179	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTEN—thyroid cancer	1.74e-05	0.000178	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTEN—thyroid cancer	1.69e-05	0.000173	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TPR—thyroid cancer	1.69e-05	0.000173	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PPARG—thyroid cancer	1.68e-05	0.000171	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.66e-05	0.00017	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.65e-05	0.000169	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—thyroid cancer	1.63e-05	0.000166	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—thyroid cancer	1.63e-05	0.000166	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTGS2—thyroid cancer	1.58e-05	0.000161	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.55e-05	0.000158	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC5A5—thyroid cancer	1.55e-05	0.000158	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.53e-05	0.000156	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—thyroid cancer	1.52e-05	0.000155	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARG—thyroid cancer	1.51e-05	0.000154	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.51e-05	0.000154	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.45e-05	0.000148	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—thyroid cancer	1.42e-05	0.000145	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.39e-05	0.000142	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTEN—thyroid cancer	1.38e-05	0.000141	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.35e-05	0.000138	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARG—thyroid cancer	1.33e-05	0.000136	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—thyroid cancer	1.32e-05	0.000135	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—thyroid cancer	1.32e-05	0.000135	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.3e-05	0.000133	CbGpPWpGaD
Glyburide—ALB—Metabolism—RXRA—thyroid cancer	1.3e-05	0.000133	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.26e-05	0.000129	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.26e-05	0.000129	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NRAS—thyroid cancer	1.24e-05	0.000126	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—thyroid cancer	1.24e-05	0.000126	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000121	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.19e-05	0.000121	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—RXRA—thyroid cancer	1.17e-05	0.000119	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—thyroid cancer	1.15e-05	0.000118	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—RXRA—thyroid cancer	1.14e-05	0.000116	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.13e-05	0.000116	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TPR—thyroid cancer	1.11e-05	0.000114	CbGpPWpGaD
Glyburide—ABCC1—Disease—NRAS—thyroid cancer	1.1e-05	0.000113	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.1e-05	0.000112	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—thyroid cancer	1.07e-05	0.000109	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—RXRA—thyroid cancer	1.06e-05	0.000109	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—thyroid cancer	1.05e-05	0.000107	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—thyroid cancer	1.04e-05	0.000106	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.03e-05	0.000106	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—thyroid cancer	1.01e-05	0.000103	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—thyroid cancer	9.75e-06	9.95e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—thyroid cancer	9.5e-06	9.7e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—thyroid cancer	9.47e-06	9.67e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—thyroid cancer	9.11e-06	9.31e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—thyroid cancer	9.05e-06	9.25e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC5A5—thyroid cancer	8.34e-06	8.52e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARG—thyroid cancer	8.2e-06	8.37e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—thyroid cancer	8.07e-06	8.24e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—thyroid cancer	7.99e-06	8.16e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—thyroid cancer	7.95e-06	8.11e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—thyroid cancer	7.62e-06	7.78e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARG—thyroid cancer	7.36e-06	7.51e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARG—thyroid cancer	7.18e-06	7.33e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—thyroid cancer	7.13e-06	7.28e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—RXRA—thyroid cancer	7.01e-06	7.16e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARG—thyroid cancer	6.71e-06	6.85e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—thyroid cancer	6.63e-06	6.77e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—thyroid cancer	6.45e-06	6.59e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—thyroid cancer	5.97e-06	6.1e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—thyroid cancer	5.79e-06	5.91e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—thyroid cancer	5.65e-06	5.77e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—thyroid cancer	5.62e-06	5.74e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—thyroid cancer	5.28e-06	5.39e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—thyroid cancer	5.25e-06	5.36e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—thyroid cancer	5.05e-06	5.16e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—thyroid cancer	4.93e-06	5.03e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—thyroid cancer	4.6e-06	4.7e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARG—thyroid cancer	4.43e-06	4.52e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.48e-06	3.55e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—thyroid cancer	3.24e-06	3.31e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—thyroid cancer	3.04e-06	3.1e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—thyroid cancer	2.91e-06	2.97e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—thyroid cancer	2.84e-06	2.9e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—thyroid cancer	2.65e-06	2.71e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—thyroid cancer	1.75e-06	1.79e-05	CbGpPWpGaD
